AYURF

$0.00-$0.01 (-72.22%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.00 – $0.03

0% from low

Exchange

OTC Link

Borrow rate

0.40%

Easy to borrow

Price (6 mo)

Loading chart…

Change$-0.12

Valuation

Trading at 0.0× sales vs its 0.3× historical median P/S.

Fair value ≈ $0.04 · price $0.00 today

Undervalued · 94% below

Loading valuation…

Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.

Valuation

Financials

Loading chart…

Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.

	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$7.6M	$9.4M	$12.5M	$25.2M	$31.1M
Cost of revenue	$0	$0	$0	$3.0M	$7.2M	$8.8M	$16.7M	$20.9M
Gross profit	$0	$0	$0	$4.6M	$2.2M	$3.7M	$8.5M	$10.2M
Gross margin	—	—	—	60.6%	23.7%	29.5%	33.6%	32.7%
R&D	$0	$0	$0	$0	$0	$0	$0	$0
Operating income	−$296.7K	−$257.1K	−$244.8K	$2.2M	−$3.3M	−$5.3M	−$3.3M	−$2.8M
EBITDA	−$296.7K	−$257.1K	−$244.8K	$2.5M	−$3.0M	−$4.1M	−$2.0M	−$1.8M
Net income	−$272.8K	−$222.8K	−$236.9K	−$278.4K	−$3.1M	−$5.3M	−$4.0M	−$3.5M
Net margin	—	—	—	-3.6%	-32.9%	-42.5%	-15.8%	-11.2%
EPS (diluted)	-0.02	-0.01	-0.01	-0.00	-0.03	-0.04	-0.02	-0.01

Annual figures · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
AYURFAyurcann Holdings Corp.	$0.00	+0.00%	$389408	—
AYRWFAyr Wellness Inc.	$0.01	-12.50%	$2M	—
BGXXBright Green Corporation	$0.04	+5328.57%	$7M	—
CBIHCannabis Bioscience International Holdings, Inc.	$0.00	+20.00%	$3M	—
CLCFFChristina Lake Cannabis Corp.	$0.02

AYURCANN HLDGS CORP

Held by traders on TradeandTell

No one on the platform currently holds AYURF.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in AYURF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2017-12-11	1-for-2reverse

Recent trades on TradeandTell

No one on the platform has traded AYURF yet.

$AYURF chatter on StockTwits

MAS@MkSlmnAug 6
$AYURF $AYUR WILL SEE $1/Share this year. Business combination
View on StockTwits ↗
Troy welsh@Troystgatguy56Apr 4
$AYURF this stock will 10x within a year
View on StockTwits ↗
K.C.@CONWELLBullishMar 11
$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗
K.C.@CONWELLBullishMar 8
$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗
K.C.@CONWELLBullishMar 5
$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗
K.C.@CONWELLBullishMar 4
$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗
K.C.@CONWELLBullishMar 4
$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗
K.C.@CONWELLBullishFeb 29
$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗
sue scott@Money_RunnerBullishFeb 28
$AYURF News- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q2-2024-FEATURING-A-141-INCREASE-IN-GROSS-REVENUE?id=431780
View on StockTwits ↗
K.C.@CONWELLBullishFeb 27
$AYURF Investor Presentation - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://ayurcann.com/wp-content/uploads/2023/12/1-Ayurcann-Investor-Presentation-December-3.pdf
View on StockTwits ↗
K.C.@CONWELLBullishFeb 23
$AYURF Investor Presentation - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd https://ayurcann.com/wp-content/uploads/2023/12/1-Ayurcann-Investor-Presentation-December-3.pdf
View on StockTwits ↗
K.C.@CONWELLBullishFeb 20
$AYURF - #otcmarkets #Hemp #wellness #cannabis #nysc #nasdaq #potstocks #cannabiscommunity #cbd #thc #thcd http://www.ayurcann.com/
View on StockTwits ↗
K.C.@CONWELLBullishFeb 20
$AYURF News- AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE https://www.otcmarkets.com/stock/AYURF/news/AYURCANN-REPORTS-RECORD-SALES-IN-Q1-2024-FEATURING-A-249-INCREASE-IN-GROSS-REVENUE?id=422945
View on StockTwits ↗
K.C.@CONWELLBullishFeb 18
$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗
K.C.@CONWELLBullishFeb 16
$AYURF News - Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs https://www.otcmarkets.com/stock/AYURF/news/Ayurcann-Provides-a-Corporate-Update-Completes-Debt-Settlement-and-Grants-Options-and-RSUs?id=426367
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.